Navellier & Associates Inc Novo Nordisk A S Transaction History
Navellier & Associates Inc
- $805 Million
- Q1 2024
A detailed history of Navellier & Associates Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Navellier & Associates Inc holds 113,831 shares of NVO stock, worth $16.2 Million. This represents 1.82% of its overall portfolio holdings.
Number of Shares
113,831
Previous 112,347
1.32%
Holding current value
$16.2 Million
Previous $11.6 Million
25.75%
% of portfolio
1.82%
Previous 1.76%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,854Shares Held
309MCall Options Held
5.29MPut Options Held
4.93M-
Jennison Associates LLC21.1MShares$3.01 Billion1.82% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.7MShares$1.96 Billion0.83% of portfolio
-
Bank Of America Corp Charlotte, NC13.1MShares$1.86 Billion0.16% of portfolio
-
Morgan Stanley New York, NY12MShares$1.71 Billion0.13% of portfolio
-
Fayez Sarofim & CO Houston, TX11.8MShares$1.69 Billion4.6% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $322B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...